TITAN PHARMACEUTICALS INC — Director's Dealing 2008

Jan 4, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (AMEX - TTP)
CIK: 0000910267
Period of Report: 2008-01-02

Reporting Person: FARRELL ROBERT EDWARD (Exec Vice President and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-01-02	Option to Purchase Common Stock	$1.64	A	80000	Acquired	2018-01-02	Common Stock (80000)	Direct

Footnotes

F1: Options to purchase 50% of the shares vest on January 2, 2009 and the remaining options to purchase 50% of the shares vest in twelve equal monthly installments beginning on February 2, 2009.